FDA Approval Status for Palomar Fractional Resurfacing

Palomar fractional resurfacing is a procedure used by many dermatologists to improve cosmetic skin conditions quickly and affordably. This technique is used in the treatment of acne, wrinkles, surgical scars, irregularities of pigmentation and texture, blotchy skin and crow's feet, on sensitive areas of the body such as the face, neck, hands and legs. A series of micro-beams promote the coagulation of skin in targeted areas and the regeneration of new tissue in those areas.

FDA Approval Status for Palomar Fractional Resurfacing

The FDA (Food and Drug Administration) granted approval to Palomar Plasma Skin Rejuvenation for meeting the quality and safety standards set by the administration. The approval granted in 2008 applies to various applications such as the reduction of wrinkles, the control of acne and the reduction of stretchmarks, rosacea, melasma and sun damage. The approval was also granted for vein removal and the treatment of skin lesions. The approval is mainly for the safety offered by Palomar fractional resurfacing, as it is a technique that has a low number of side effects, risks and complications associated with it.

Palomar fractional resurfacing is an outpatient procedure with a short recovery time. It uses small pulses of plasma on targeted tissue, while leaving healthy tissue intact. Approval by the FDA has made Palomar the preferred choice for various cosmetic and surgical applications.